CARCIERI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 152
AS - Asia 62
SA - Sud America 5
AF - Africa 3
OC - Oceania 2
Totale 452
Nazione #
US - Stati Uniti d'America 223
IT - Italia 76
CN - Cina 27
IN - India 18
GB - Regno Unito 15
FR - Francia 11
DE - Germania 9
ES - Italia 8
NL - Olanda 7
IE - Irlanda 5
GR - Grecia 4
RU - Federazione Russa 4
VN - Vietnam 4
BR - Brasile 3
DK - Danimarca 3
MX - Messico 3
AU - Australia 2
CA - Canada 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GE - Georgia 2
ID - Indonesia 2
IL - Israele 2
JP - Giappone 2
PL - Polonia 2
PT - Portogallo 2
TH - Thailandia 2
BE - Belgio 1
CH - Svizzera 1
IR - Iran 1
JO - Giordania 1
LT - Lituania 1
RS - Serbia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 452
Città #
Torino 47
Fairfield 30
Woodbridge 27
Ann Arbor 19
Buffalo 19
Houston 17
Ashburn 13
Seattle 12
Wilmington 11
Cambridge 8
Wuhan 7
Amsterdam 5
Dublin 4
Kumar 4
Santa Cruz 4
Beijing 3
Chicago 3
Hyderabad 3
Las Vegas 3
Madrid 3
Nanjing 3
San Diego 3
Tarragona 3
Bengaluru 2
Easton 2
Fleming Island 2
Hangzhou 2
Henderson 2
Ho Chi Minh City 2
Jerusalem 2
Leinì 2
London 2
Miguel Hidalgo 2
Mountain View 2
Mumbai 2
New York 2
Niles 2
Phoenix 2
Pisa 2
Rio De Janeiro 2
Tianjin 2
University Park 2
Warsaw 2
Bad Vilbel 1
Birmingham 1
Bloomington 1
Boardman 1
Bonn 1
Braga 1
Cairo 1
Changchun 1
Changshahsien 1
Cheyenne 1
Chiyoda-ku 1
Clearwater 1
Copenhagen 1
Dallas 1
Des Moines 1
Dong Ket 1
Gazzada 1
Girona 1
Giza 1
Greifswald 1
Hat Yai 1
Hebei 1
Hefei 1
Heswall 1
Jakarta 1
Lake Forest 1
Los Angeles 1
Lucca 1
Marneuli 1
Melbourne 1
Memphis 1
Muizenberg 1
Nanchang 1
Napoli 1
New Orleans 1
Newcastle Upon Tyne 1
Nieder-wiesen 1
Nijmegen 1
Ottawa 1
Piemonte 1
Provo 1
Rochester 1
Saint Etienne 1
Saint Louis 1
Salem 1
Santiago 1
Stuttgart 1
São Paulo 1
Taipei 1
Tbilisi 1
Toronto 1
Washington 1
West Chester 1
Échirolles 1
Totale 345
Nome #
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children, file e27ce42c-0323-2581-e053-d805fe0acbaa 303
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection, file e27ce42c-2693-2581-e053-d805fe0acbaa 88
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce433-9ce4-2581-e053-d805fe0acbaa 23
Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study, file e27ce42c-25e6-2581-e053-d805fe0acbaa 8
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children, file e27ce42b-eb8d-2581-e053-d805fe0acbaa 6
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study, file e27ce42d-7321-2581-e053-d805fe0acbaa 6
UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma, file e27ce42b-ee07-2581-e053-d805fe0acbaa 4
Role of simeprevir plasma concentrations in HCV treated patients with dermatological symptoms, file e27ce42b-ee7b-2581-e053-d805fe0acbaa 4
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients, file e27ce42c-45f1-2581-e053-d805fe0acbaa 4
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy, file e27ce42d-7323-2581-e053-d805fe0acbaa 4
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors, file e27ce42c-1a28-2581-e053-d805fe0acbaa 3
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs, file e27ce42c-586b-2581-e053-d805fe0acbaa 3
Pharmacogenetic of voriconazole antifungal agent in pediatric patients, file e27ce42d-7320-2581-e053-d805fe0acbaa 3
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce42a-c0ee-2581-e053-d805fe0acbaa 2
Cannabinoids concentration variability in cannabis olive oil galenic preparations, file e27ce42c-9627-2581-e053-d805fe0acbaa 2
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children, file e27ce432-5075-2581-e053-d805fe0acbaa 2
Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia, file e27ce42a-8c84-2581-e053-d805fe0acbaa 1
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia, file e27ce42b-b4ec-2581-e053-d805fe0acbaa 1
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients, file e27ce42b-b4ed-2581-e053-d805fe0acbaa 1
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children, file e27ce42c-091c-2581-e053-d805fe0acbaa 1
A LC-MS method to quantify tenofovir urinary concentrations in treated patients, file e27ce431-c024-2581-e053-d805fe0acbaa 1
Totale 470
Categoria #
all - tutte 557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201819 0000 00 04 2436
2018/201983 5252 45 56 6141811
2019/202093 1131215 76 75 11727
2020/202184 1545 46 311 75285
2021/2022110 822626 141 52 7874
2022/202358 33119 914 90 0000
Totale 470